Hamlet Pharma, soon to be Hamlet BioPharma following the merger with SelectImmune Pharma, has appointed Petter Segelman Lindqvist as its new CEO, starting October 1, 2023. He replaces Martin Erixon, who will…
Hamlet Pharma, soon to be Hamlet BioPharma following the merger with SelectImmune Pharma, has appointed Petter Segelman Lindqvist as its new CEO, starting October 1, 2023. He replaces Martin Erixon, who will…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


